AI assistant
Sending…
RESMED INC — Director's Dealing 2019
Jul 31, 2019
30071_dirs_2019-07-31_1e46e349-47ce-4f70-882c-ebbf51057905.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-07-29
Reporting Person: McHale Richard (President, RC Business)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-07-29 | ResMed Common Stock | S | 12306 | $127.057 | Disposed | 11215 | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $126.62 to $127.60. The price reported above reflects the weighted average sale price.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29